S5 Ep9: Writing a Book Helped a Survivor Process Fears of Cancer Recurrence
Cancer Horizons10 Marras 2022

S5 Ep9: Writing a Book Helped a Survivor Process Fears of Cancer Recurrence

For Tara Rolle, the treatment was the easy part of her cancer experience.
Diagnosed with small-cell neuroendocrine cervical cancer, a rare and aggressive form of cancer, at 37, Rolle was initially shocked but then jumped into planning mode. She rallied her family for support, figured out the most appropriate way to explain the situation to her teenage daughter and even managed to continue her job as a San Francisco school superintendent while undergoing treatment.
At The University of Texas MD Anderson Cancer Center, Rolle received overlapping cancer treatment. After undergoing six rounds of chemotherapy, 30 rounds of external-beam radiation and three brachytherapies (when radioactive sources are placed inside the patient to kill cancer cells and shrink tumors), Rolle was officially declared free of cancer in July 2020 — five months after first being diagnosed.
While Rolle’s family was relieved and ready to move on, Rolle was unable to join them.
Fears of cancer recurrence plagued her, and she found herself taking long walks and writing down these thoughts, which she dubbed “the white noise of survivorship,” in an attempt to give them less power over her mindset.
Realizing that these long messages could help communicate her feelings of anxiety to her family and help other survivors in similar situations, Rolle decide to put them into a book, “The White Noise of Survivorship: and Other Unsolicited Lessons I Learned From Cancer.”
In today’s episode of the “Cancer Horizons” podcast, Rolle shares the unexpected upsides of undergoing cancer treatment during the COVID-19 pandemic, why she chose to not initially go public with her diagnosis, how writing her book helped process her fears of cancer recurrence and more.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(295)

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...

31 Joulu 202514min

S7 Ep1: The Importance of Spotting Endometrial Cancer

S7 Ep1: The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

18 Maalis 202510min

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

17 Syys 202419min

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...

4 Maalis 20247min

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...

4 Maalis 202410min

S6 Ep20: FDA Approvals from February 2024

S6 Ep20: FDA Approvals from February 2024

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...

23 Helmi 20246min

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

Last week, we saw some FDA approvals for a new drug regimens, as well as some expert opinion about cancer vaccines. Additionally research touched upon the potential benefit of concurrent ctDNA and tum...

19 Helmi 20249min

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews. Also last week, we covered researc...

12 Helmi 20247min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-hereilla
rss-duodecim-lehti
rss-poliisin-mieli
rss-ilmasto-kriisissa
tiedekulma-podcast
docemilia
hippokrateen-vastaanotolla
sotataidon-ytimessa
rss-radplus
rss-tiedetta-vai-tarinaa
rss-opeklubi
rss-kasvikutsut
rss-totuuden-liepeilla